313 related articles for article (PubMed ID: 9229341)
1. Stereospecific formulation and characterization of sustained release ibuprofen microspheres.
Janjikhel RK; Adeyeye CM
J Microencapsul; 1997; 14(4):409-26. PubMed ID: 9229341
[TBL] [Abstract][Full Text] [Related]
2. Chemical, dissolution stability and microscopic evaluation of suspensions of ibuprofen and sustained release ibuprofen-wax microspheres.
Adeyeye CM; Price JC
J Microencapsul; 1997; 14(3):357-77. PubMed ID: 9147285
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of sustained-release ibuprofen-wax microspheres. I. Effect of formulation variables on physical characteristics.
Adeyeye CM; Price JC
Pharm Res; 1991 Nov; 8(11):1377-83. PubMed ID: 1798673
[TBL] [Abstract][Full Text] [Related]
4. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS
Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (Eudragit) by quasi-emulsion solvent diffusion method: effect of variables.
Devrim B; Canefe K
Acta Pol Pharm; 2006; 63(6):521-34. PubMed ID: 17438870
[TBL] [Abstract][Full Text] [Related]
6. Determination of ibuprofen solubility in wax: a comparison of microscopic, thermal and release rate techniques.
Oladiran GS; Batchelor HK
Eur J Pharm Biopharm; 2007 Aug; 67(1):106-11. PubMed ID: 17321730
[TBL] [Abstract][Full Text] [Related]
7. In-vitro evaluation of sustained release ibuprofen microspheres.
Ghaly ES; Sepúlveda S
P R Health Sci J; 1996 Jun; 15(2):97-100. PubMed ID: 8936613
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of sustained-release ibuprofen-wax microspheres. II. In vitro dissolution studies.
Adeyeye CM; Price JC
Pharm Res; 1994 Apr; 11(4):575-9. PubMed ID: 8058619
[TBL] [Abstract][Full Text] [Related]
9. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
[TBL] [Abstract][Full Text] [Related]
10. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
[TBL] [Abstract][Full Text] [Related]
11. Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. I. Oil-in-water technique for water-insoluble drugs.
Bodmeier R; Wang J; Bhagwatwar H
J Microencapsul; 1992; 9(1):89-98. PubMed ID: 1613647
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro.
Fernández-Carballido A; Herrero-Vanrell R; Molina-Martínez IT; Pastoriza P
Int J Pharm; 2004 Jul; 279(1-2):33-41. PubMed ID: 15234792
[TBL] [Abstract][Full Text] [Related]
13. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
Jelvehgari M; Atapour F; Nokhodchi A
Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
[TBL] [Abstract][Full Text] [Related]
14. Initial salt screening procedures for manufacturing ibuprofen.
Lee T; Wang YW
Drug Dev Ind Pharm; 2009 May; 35(5):555-67. PubMed ID: 19005918
[TBL] [Abstract][Full Text] [Related]
15. Formulation of a extended release tablet containing dexibuprofen.
Yi HG; Chi MH; Kim YI; Woo JS; Park ES
Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization, and dissolution studies of ibuprofen solid dispersions using polyethylene glycol (PEG), talc, and PEG-talc as dispersion carriers.
Khan GM; Jiabi Z
Drug Dev Ind Pharm; 1998 May; 24(5):455-62. PubMed ID: 9876608
[TBL] [Abstract][Full Text] [Related]
17. Effects of formulation variables and characterization of guaifenesin wax microspheres for controlled release.
Mani N; Park MO; Jun HW
Pharm Dev Technol; 2005; 10(1):71-83. PubMed ID: 15776815
[TBL] [Abstract][Full Text] [Related]
18. Development of novel ibuprofen-loaded solid dispersion with enhanced bioavailability using cycloamylose.
Baek HH; Kim DH; Kwon SY; Rho SJ; Kim DW; Choi HG; Kim YR; Yong CS
Arch Pharm Res; 2012 Mar; 35(4):683-9. PubMed ID: 22553061
[TBL] [Abstract][Full Text] [Related]
19. Melt solidification technique: incorporation of higher wax content in ibuprofen beads.
Kamble R; Maheshwari M; Paradkar A; Kadam S
AAPS PharmSciTech; 2004 Oct; 5(4):e61. PubMed ID: 15760058
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administration.
Mathew ST; Devi SG; KV S
AAPS PharmSciTech; 2007 Feb; 8(1):14. PubMed ID: 17408214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
